1. Home
  2. GNT vs MDXH Comparison

GNT vs MDXH Comparison

Compare GNT & MDXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GAMCO Natural Resources Gold & Income Trust

GNT

GAMCO Natural Resources Gold & Income Trust

HOLD

Current Price

$8.86

Market Cap

135.5M

Sector

Finance

ML Signal

HOLD

Logo MDxHealth SA

MDXH

MDxHealth SA

HOLD

Current Price

$2.29

Market Cap

149.0M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
GNT
MDXH
Founded
2011
2003
Country
United States
Belgium
Employees
N/A
N/A
Industry
Finance/Investors Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
135.5M
149.0M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
GNT
MDXH
Price
$8.86
$2.29
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$7.67
AVG Volume (30 Days)
65.6K
254.9K
Earning Date
01-01-0001
05-14-2026
Dividend Yield
6.61%
N/A
EPS Growth
N/A
N/A
EPS
0.95
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$30.78
Revenue Next Year
N/A
$18.31
P/E Ratio
$9.27
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.87
$1.67
52 Week High
$9.30
$5.33

Technical Indicators

Market Signals
Indicator
GNT
MDXH
Relative Strength Index (RSI) 56.95 40.67
Support Level $7.76 $1.93
Resistance Level $9.30 $2.75
Average True Range (ATR) 0.19 0.18
MACD 0.03 0.05
Stochastic Oscillator 63.27 80.54

Price Performance

Historical Comparison
GNT
MDXH

About GNT GAMCO Natural Resources Gold & Income Trust

GAMCO Natural Resources, Gold & Income Trust is a non-diversified closed-end management investment company. The company's primary investment objective is to provide a high level of current income from interest, dividends, and options premiums with its secondary objective being capital appreciation. Under normal market conditions, the company invests majority of its assets in securities of companies principally engaged in the natural resources and gold industries, and also engages in writing covered call options on the underlying equity securities. Its portfolio consists of securities from different sectors such as metals and mining, energy and energy services, specialty chemicals, agriculture, healthcare, machinery, food and beverage, and others.

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

Share on Social Networks: